Free CME from PeerView


Hematology CME

Robert Z. Orlowski, MD, PhD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options
July 27, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Path for Better Outcomes in ALL: Integrating Modern Asparaginase Compounds Into the Care of Pediatric, AYA, and Adult Patients
July 19, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL
July 15, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management
July 15, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Navigating From A to B and C in Multiple Myeloma: Delivering High-Quality Care With mAbs, BCMA ADCs, and Cellular Therapy
July 12, 2022
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Applying Therapeutic Innovations Against ALL: From Updated Evidence to Everyday Practice
June 30, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The "Myelennial" Generation: Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes
June 05, 2022
Jason Westin, MD, MS, FACP
Credits: 1.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
June 05, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
The Advantage of Innovation in AML: Guidance on Developing and Delivering Effective and Highly Personalized Care
June 04, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care
June 04, 2022
Jeanne M. Palmer, MD/Srdan Verstovsek, MD, PhD
Credits: 1.0 CME
The Medical College of Wisconsin
The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
May 27, 2022
Nelson Chao, MD, MBA/Christine N. Duncan,MD
Credits: 1.0 CME
The Medical College of Wisconsin
Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment
May 26, 2022
John N. Allan, MD
Credits: 1.0 CME
The Medical College of Wisconsin
Reaping the Rewards of Innovative Care in CLL: From Targeted Strategies to Cellular Therapy
May 24, 2022
Credits: 1.0 CME
The Medical College of Wisconsin
Overcoming the Challenges of Acute and Chronic GVHD: The Integration of Novel Therapies Into Modern Management Protocols
May 19, 2022
James M. Foran, MD, FRCPC
Credits: 1.0 CME
The Medical College of Wisconsin
Landmarks Across the Patient Journey in AML: Applying Evidence With Novel Therapeutics Pre- and Post-AlloHCT
May 18, 2022
Credits: 1.0 CME / MOC / NCPD
Penn State College of Medicine
Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing
May 09, 2022
Credits: 0.25 CME / CPE
Medical Learning Institute, Inc.
Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care
May 06, 2022
Credits: 1.0 CME / MOC / CPE
Medical Learning Institute, Inc.
Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy
May 06, 2022
Credits: 1.0 CME / CPE
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
May 06, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Revolutionizing the Standard of NF1 Care: Insights on Innovative MEK-Inhibitor Options for NF1-Associated PNs
May 05, 2022
Stuart S. Winter, MD
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Adapting to Innovation in Pediatric ALL: Guidance on Optimizing Modern Therapy and the Role of Novel Asparaginase Compounds
May 05, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium
May 04, 2022
Credits: 1.0 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps
April 29, 2022
Amy Goodrich, CRNP
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Hope Is Here in CLL: Oncology Nurse Strategies for Delivering Effective, Compassionate, and Modern Care to Patients
April 29, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
April 28, 2022
Credits: 1.0 CME / NCPD / CE
PVI, PeerView Institute for Medical Education
Building Skills for Clinical Practice: Optimizing Insulin Management and Personalizing Diabetes Care With Faster-Acting Formulations and Newer Options in Delivery Technology
April 27, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
April 27, 2022
Credits: 0.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
April 27, 2022

Pages